Metastatic Uveal Melanoma Global Clinical Trials Review, H2, 2017

  • ID: 4459330
  • Clinical Trials
  • Region: Global
  • 69 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Array BioPharma Inc
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Celgene Corp
  • Celldex Therapeutics Inc
  • Eli Lilly and Co
  • MORE
Metastatic Uveal Melanoma Global Clinical Trials Review, H2, 2017

Summary

The clinical trial report, “Metastatic Uveal Melanoma Global Clinical Trials Review, H2, 2017" provides an overview of Metastatic Uveal Melanoma clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Uveal Melanoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using the author’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc. across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Array BioPharma Inc
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Celgene Corp
  • Celldex Therapeutics Inc
  • Eli Lilly and Co
  • MORE
Report Guidance
Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Clinical Trials by G7 Countries: Proportion of Metastatic Uveal Melanoma to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Metastatic Uveal Melanoma Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Metastatic Uveal Melanoma
Nov 13, 2017: Immunocore Presents Single Agent IMCgp100 data in Metastatic Uveal Melanoma Showing Durability, Doubling in One-Year Overall Survival Rate
Oct 31, 2017: Immunocore to Present New Overall Survival Data in Metastatic Uveal Melanoma at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About
Contact
Disclaimer
Source

List of Tables
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Region, 2017*
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, North America, Top Countries, 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017*
Proportion of Metastatic Uveal Melanoma to Oncology Clinical Trials, G7 Countries (%), 2017*
Metastatic Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
Metastatic Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Phase, 2017*
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase 2017*
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, by End Point Status, 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Metastatic Uveal Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*

List of Figures
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Region (%), 2017*
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, North America, Top Countries (%), 2017*
Proportion of Metastatic Uveal Melanoma to Oncology Clinical Trials, G7 Countries (%), 2017*
Metastatic Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
Metastatic Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Phase (%), 2017*
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2017*
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, by End Point Status, 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Metastatic Uveal Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*
Methodology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Novartis AG
  • AstraZeneca Plc
  • Eli Lilly and Co
  • Pfizer Inc
  • Bristol-Myers Squibb Co
  • Laboratory Corp of America Holdings
  • Immunocore Ltd
  • Celldex Therapeutics Inc
  • Celgene Corp
  • Array BioPharma Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll